Anna Pawlus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Pawlus has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Dawid Domasławski
Wroclaw Medical University Wrocław Poland
1 shared publication - Karol Zagórski
University Center of Excellence in Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland
1 shared publication - Mateusz Mierniczek
St. Raphael’s Voivodeship Specialist Hospital in Czerwona Góra, Chęciny, Poland
1 shared publication - Szymon Andrzej Czerski
Wroclaw Medical University, Wrocław, Poland
1 shared publication - Łukasz Sabik
Wroclaw Medical University Wrocław Poland
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Medical Education in OncoReview
- Vol. 15 (2(58)) , 46-54
Small Intestinal Bacterial Overgrowth (SIBO) and cancer. A comprehensive review of emerging connections
Small Intestinal Bacterial Overgrowth (SIBO) is increasingly recognized in oncology. It often complicatestreatment, reduces quality of life, and may contribute to carcinogenesis through chronic inflammation.Diagnostic breath tests, widely used for SIBO, show promise in early detection of colorectal polypsand cancer. Current therapies (antibiotics, diet, probiotics) provide partial relief, but data in oncologyremain limited. Recognizing and managing SIBO in cancer care may improve outcomes and requiresfurther research.
- 30 September 2025
- Published by Medical Education in OncoReview
- Vol. 15 (2(58)) , 46-54
Open AccessSmall Intestinal Bacterial Overgrowth (SIBO) and cancer. A comprehensive review of emerging connections
Small Intestinal Bacterial Overgrowth (SIBO) is increasingly recognized in oncology. It often complicatestreatment, reduces quality of life, and may contribute to carcinogenesis through chronic inflammation.Diagnostic breath tests, widely used for SIBO, show promise in early detection of colorectal polypsand cancer. Current therapies (antibiotics, diet, probiotics) provide partial relief, but data in oncologyremain limited. Recognizing and managing SIBO in cancer care may improve outcomes and requiresfurther research.